Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/42759
Title: | First-line (1L) maintenance therapy with niraparib (nira) plus pembrolizumab (pembro) vs placebo plus pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase III ZEAL-1L study |
Authors: | RAMALINGAM, S. S.; CASTRO JR., G. de; GARASSINO, M. C. C.; MAZIERES, J.; SANBORN, R. E.; SMIT, E. F. F.; SPIGEL, D. R.; THOMAS, M.; VELCHETI, V.; ZHI, E.; NEIBAUER, M. Whipple; STOJADINOVIC, A.; PETERS, S. |
Citation: | ANNALS OF ONCOLOGY, v.32, suppl.5, p.S1030-S1032, 2021 |
Appears in Collections: | Comunicações em Eventos - FM/MDR Comunicações em Eventos - HC/ICESP Comunicações em Eventos - LIM/24 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.